
Dr. Sanket Newale
Medical Affairs leader, clinician, and clinical researcher
Summary
Work
Education
Writing
Efficacy and Safety of Oral and IV Levonadifloxacin Therapy in Management of Bacterial Infections: Findings of a Prospective, Observational, Multi-center, Post-marketing Surveillance Study
February 1, 2024Prospective, multicenter post-marketing observational study reporting safety and efficacy outcomes of oral and IV levonadifloxacin across multiple infection types; includes clinical and microbial success rates from 1266 patients.
Beta-Adrenergic Blockade: Is It the Prudent Choice against Sympathetic Overdrive in Patients with Hypertension or Heart Failure?
December 1, 2022Review discussing sympathetic overdrive in hypertension and heart failure with emphasis on beta-blocker therapy and the potential role of S-metoprolol.
Real World Evidence of Safety and Effectiveness of Combination (example article noted in sources)
January 1, 2020Contributed to drafting/editing and acknowledged in multi-author real-world evidence publications (example items appear in verified source list).
Demographic characteristics of epilepsy patients and antiepileptic drug utilization in adult patients: Results of a cross-sectional survey
January 1, 2016Cross-sectional study reporting demographics and antiepileptic drug utilization in 973 adult epilepsy patients; includes AED usage patterns and comorbidity data.
Detection, Management Approach of Depression and Antidepressant Utilization in Adult Patients: Results of a Cross-Sectional Survey
January 1, 2016Large cross-sectional observational study of depression management patterns in India, describing demographics, comorbidities, and antidepressant utilization.